THE PRIX GALIEN USA
Improving the Human Condition
"...considered the industry's equivalent of the Nobel Prize..."
The Prix Galien recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is now considered the industry’s equivalent of the Nobel Prize, the highest accolade for pharmaceutical research and development.
The Prix Galien was inaugurated in the United States in September 2007 under the auspices of an exceptional awards committee that includes 7 Nobel Laureates.
The second edition of the Prix Galien USA Awards will be held
on Wednesday,
September 24th 2008,
at
the American Museum of Natural history in New York City.
Sponsorship Opportunities for the 2008 Awards Ceremony
Limited sponsorship opportunities are available.
Contact David Quigley or Marian Temesvary at (312) 422-0405 or dquigley@prix-galien-usa.com
THE PRIX GALIEN USA 2007 WINNERS
The Award for Best Biotechnology Product:
Merck & Co., Inc. for Gardasil and Abbott Laboratories for Humira.
The Award for Best Pharmaceutical Agent:
Merck & Co., Inc. for Januvia and Pfizer for Chantix.
The Pro Bono Humanum Award:
Physician, scientist, educator and pharmaceutical company executive Roy Vagelos, M.D., for his historic decision to donate the drug Mectizan® to more than 530 million people in 34 countries to treat and prevent river blindness "as much as necessary for as long as necessary".
From President Jimmy Carter, September 21, 2007
"To Dr. Roy Vagelos:
Rosalynn joins me in congratulating you on receiving the 2007 Galien Pro Bono Humanum Prize
at the Prix Galien Awards Ceremony. We always have been inspired by your decision,
on behalf
of Merck & Co., Inc., to donate Mectizan® free of charge to all who need it
for as long
as necessary."
From Michael Bloomberg, Mayor of New York City. September 25, 2007
"Dear Friends:
It is a pleasure to welcome everyone to the first Prix Galien USA Awards Ceremony. Since its
establishment in France in 1970, the prestigious Prix Galien has honored leaders whose groundbreaking
work in the pharmaceutical and biomedical sectors have improved the health and quality of life for
countless men and women around the globe."
